Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–143 of 143 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: IV iron Clear all

Conditions: Iron Deficiency Anemia, Inflammatory Bowel Disease
Interventions: Intravenous iron sucrose, Oral ferrous sulfate; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 12 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Nervous System Diseases, Diagnostic Imaging
Interventions: Ferumoxytol; Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cystic Fibrosis
Interventions: Adults - CFPE Treatment; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: South Portland, Maine • Lebanon, New Hampshire

Conditions: Prostate Cancer, Bladder Cancer, Kidney Cancer
Interventions: Ferumoxytol, Magnetic Resonance Imaging (MRI); Drug · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: End Stage Renal Disease
Interventions: Triferic, Heparin; Drug
Lead sponsor: Rockwell Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: AIDS Dementia Complex
Interventions: Ferumoxytol; Drug
Lead sponsor: Beau Nakamoto; Other
Eligibility: 40 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Hypertension
Interventions: clevidipine, sodium nitroprusside; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 739 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 29
States / cities: Birmingham, Alabama • Montgomery, Alabama • Burbank, California + 22 more

Conditions: Anemia, Critical Illness
Interventions: Iron Dextran, Erythropoietin (EPO); Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Iron Deficiency Anemia
Interventions: IOP Injection / MPB-1514; Drug
Lead sponsor: MegaPro Biomedical Co. Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 8
States / cities: Azusa, California • Northridge, California • Whittier, California + 5 more

Conditions: End Stage Renal Disease
Interventions: Triferic; Drug
Lead sponsor: Rockwell Medical Technologies, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 8
States / cities: Loma Linda, California • Washington D.C., District of Columbia • Indianapolis, Indiana + 5 more

Conditions: Breast Cancer, Prostate Cancer
Interventions: ferumoxytol, magnetic resonance imaging; Drug · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Iron Deficiency Anemia
Interventions: ferumoxytol; Drug
Lead sponsor: Dialysis Clinic, Inc.; Industry
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: North Brunswick, New Jersey

Conditions: Anemia, Unexplained Anemia (UAE)
Interventions: iron sucrose; Drug
Lead sponsor: Duke University; Other
Eligibility: 65 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 5
States / cities: Chicago, Illinois • Baltimore, Maryland • Cleveland, Ohio + 1 more

Conditions: Central Nervous System Neoplasm, Cranial Nerve Disorder, Metastatic Malignant Neoplasm in the Brain
Interventions: Ferumoxytol, Gadolinium, Magnetic Resonance Imaging; Drug · Procedure
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 10 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Anemia, Iron Deficiency
Interventions: IV iron; Drug
Lead sponsor: Sutter Gould Medical Foundation; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Modesto, California

Conditions: Restless Legs Syndrome, Iron Deficiency Anemia
Interventions: Ferumoxytol intravenous, Ferrous sulfate; Drug
Lead sponsor: Auerbach Hematology Oncology Associates P C; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bioequivalance
Interventions: Iron Sucrose Injection, Venofer Injection; Drug
Lead sponsor: Baxter Healthcare Corporation; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Iron Deficiency Anemia, Nondialysis-dependent Chronic Kidney Disease
Interventions: Ferumoxytol, Oral Iron; Drug
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 6 Months to 17 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Anemia, Iron-Deficiency, Kidney Failure, Chronic, Hemodialysis
Interventions: Sodium ferric gluconate,; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 29
States / cities: Bakersfield, California • Glendale, California • Los Angeles, California + 26 more

Conditions: Hypertension, Heart Failure
Interventions: Clevidipine, Standard of Care IV antihypertensive; Drug
Lead sponsor: The Medicines Company; Industry
Eligibility: 18 Years and older
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 9
States / cities: Montgomery, Alabama • Inglewood, California • Baton Rouge, Louisiana + 6 more

Conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
Interventions: Iron isomaltoside/ferric derisomaltose, Ferric carboxymaltose; Drug
Lead sponsor: Pharmacosmos A/S; Industry
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 16
States / cities: Los Angeles, California • Sacramento, California • Santa Ana, California + 9 more

Conditions: Chronic Kidney Disease, Iron-deficiency Anemia
Interventions: IV Iron, Ferrous Sulfate; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Iron Deficiency Anemia
Interventions: Ferumoxytol, Placebo; Drug · Other
Lead sponsor: AMAG Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 812 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 137
States / cities: Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 105 more

Search by objective public record fields.

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation

Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients

Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS

Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)

Practical Anemia Bundle for SusTained Blood Recovery

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Iron Indices and Intravenous Ferumoxytol: Time to Steady State

Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)

Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia